P1090: CAMRELIZUMAB (CAM) COMBINED WITH GEMOX CHEMOTHERAPY RESULTS IN HIGH COMPLETE METABOLIC RESPONSE RATES IN RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA (CHL): A PHASE II TRIAL

Detalles Bibliográficos
Autores principales: Xie, Y., Tang, Y., Zheng, W., Ping, L., Lin, N., Tu, M., Zhang, C., Ying, Z., Liu, W., Deng, L., Wu, M., Mi, L., Du, T., Wang, X., Zhu, J., Song, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429680/
http://dx.doi.org/10.1097/01.HS9.0000847228.68024.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429680/
http://dx.doi.org/10.1097/01.HS9.0000847228.68024.43

Ejemplares similares